logo
Plus   Neg
Share
Email

Stellar Biotechnologies Inc. (SBOT) Is Up Sharply On Study News

Stellar Biotechnologies Inc. (SBOT) announced Thursday morning that it has completed a research study focused on the molecular composition of its KLH products.

Stellar Biotechnologies gapped open higher this morning and is now up 1.35 at $3.00 on above average volume. The stock has jumped to nearly a 1-month high.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Follow RTT